First Product is Launched into US Marketplace

June 25th, 2012 is another milestone in the history of NOVAST.  It is the day that our first hormonal product, PHILITH™ (Norethindrone-Ethinyl Estradiol  0.4 mg/0.035 mg), is launched into the US marketplace. This launch marks a breakthrough of NOVAST prescription drugs into mainstream US markets and begins a new chapter of internationalization.